SJP 223 (Bidex-A 25 mg-600 mg)
Pill imprint SJP 223 has been identified as Bidex-A 25 mg-600 mg.
Dextromethorphan/guaifenesin is used in the treatment of expectoration; cough and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Dextromethorphan/guaifenesin 25 mg-600 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- SJP 223
- Strength:
- 25 mg-600 mg
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Stewart-Jackson Pharmacal Inc
More about dextromethorphan/guaifenesin
Consumer resources
- Dextromethorphan polistirex/guaifenesin extended-release liquid
- Dextromethorphan/guaifenesin
- Dextromethorphan/guaifenesin elixir
- Dextromethorphan/guaifenesin extended-release tablets
- Dextromethorphan/guaifenesin granule packets
- More (2) »
- Other brands: Mucinex DM, Robitussin Cough + Chest Congestion DM, Tussin DM, Q-Tussin DM, More (24) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
